2Mês·

🦎 Dividend Check: AbbVie Delivers!

Hard numbers and reliable cash flow 📊💰

Today, a $102 dividend was deposited into my account

I’ve had AbbVie in my portfolio since 2021. The results after 5 years? A whopping doubling of book profit and a steady stream of dividends that’s just a joy to watch.

Here are the facts straight from my portfolio:

📌 Position: 59 shares of AbbVie (ABBV)

🏛 Invested since: 2021

💵 Initial investment: 7,404.88 total (125.51 per share)

📈 Performance: +99.87% Paper profit (+$7,395.37)

💸 Cash Flow: $1,527.91 in dividends received

🏆 Total return:+$8,923.28 (+120.5% total return)

🔥 Bonus: The yield on cost is now a whopping 6.48%.

How about you—do you have pharmaceutical heavyweights like AbbVie in your portfolio?

$ABBV (-0,59%)

14.08

AbbVie

Recebido x59 Dividendos em US$ 1,73

US$ 102,07

6 Comentários

Poor Dad@PoorDad

2Mês

6.5% YoC is really impressive for such a top-tier company... I've been on the waitlist forever.
I'm also very happy with $MRK, though.

•

SG@RundesBalli1

1Mês

I bought them at pretty much the same time, but 100 shares

•

Johnny B.@JBatelli

2Mês

Great investment! Congratulations 👍

••

Weazlyy@Weazlyy

2Mês

Is on my radar for quite sometime, unfortunately couldn’t jump in on the recent dip. Do you think its still a good value for the long term investment?

••

finanzperpetuum@finanzperpetuum

2Mês

@Weazlyy I remain optimistic.

The Humira cliff has been more than offset by the new blockbusters. The pipeline looks promising, the strong cash flow is being used for top-tier acquisitions, and the dividend continues to grow.

I’d say AbbVie isn’t a bargain, but it’s fairly valued given its quality and growth. In the long term, that sounds very attractive to me 🤓

•

market_analyst_466@market_analyst_466

1Mês

I also own AbbVie, but not as long as you have. So I haven't reached a YoC of 6.5% yet. Congratulations on that. I also own $LLY and some very small satellite stocks like $GUBRA, $VKTX, and $CORT.

••